• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    More On 8158.HK



    News & Info


    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates


    • Major Holders
    • Insider Transactions
    • Insider Roster


    China Bio-Med Regeneration Technology Limited (8158.HK)

    0.24 0.00(0.00%) Feb 27
    Add to Portfolio
    ProfileGet Profile for:
    China Bio-Med Regeneration Technology Limited
    Dah Sing Financial Centre
    31st Floor
    Hong Kong - Map
    Phone: 852 3966 8388
    Fax: 852 2802 0026
    Website: http://www.bmregeneration.com

    Index Membership:N/A
    Full Time Employees:375

    Business Summary 

    China Bio-Med Regeneration Technology Limited, an investment holding company, is engaged in the research, development, production, and sale of tissue engineering skin related products. The company’s tissue engineering skin products include ActivSkin, which is used to cure injuries due to accidents and diseases occurring from infection, ulcer, burn, complication of surgeries, and congenital abnormalities; and Acellular Cornea for the treatment of various kinds of cornea diseases, including cornea lamellar defect, cornea alkali burn, and bacteria corneal ulcer. Its other development products comprise Selective Acellular Porcine Skin for the treatment of various skin injuries, infected, and deficient wounds, as well as enhance healing of scars and chronic non-healing ulcers and prevent recurrence; and Boactive cosmetics. The company was formerly known as B M Intelligence International Limited and changed its name to China Bio-Med Regeneration Technology Limited in December 2008. China Bio-Med Regeneration Technology Limited was founded in 1995 and is headquartered in Wanchai, Hong Kong.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on China Bio-Med Regeneration Technology Limited

    Key Executives 
    Mr. Zhengkang Shao ,
    Chief Exec. Officer
    Mr. Yumin Dai , 54
    Compliance Officer and Exec. Director
    Mr. Long Ma , 56
    Chief Internal Auditor and Non-Exec. Director
    Ms. Yurong Wang , 53
    Exec. Director
    Ms. Chan Yim ,
    Company Sec.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in HKD.